At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
SOL Nova Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling
In Brief
A clinical study evaluating SOL Nova Device for Fibrosing Alopecia and 2 related conditions. Completed, enrolled 6 participants across 1 site.
Detailed Summary
To evaluate the efficacy microneedling via a professional tattoo machine in revitalizing hair follicles in patients with fibrosing alopecia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartApr 2021
Primary CompletionApr 2022
TodayJul 2026
First PostedApr 10, 2020
Enrollment StartApr 9, 2021
Primary CompletionApr 8, 2022
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.2 years ago
Interventions
SOL Nova Devicedevice
A SOL Nova Device (brand) is tattoo machine will be used to stimulate hair regrowth.